SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 173.22 |
| Enterprise Value ($M) | 158.63 |
| Book Value ($M) | 27.70 |
| Book Value / Share | 2.21 |
| Price / Book | 6.25 |
| NCAV ($M) | 5.05 |
| NCAV / Share | 0.40 |
| Price / NCAV | 34.29 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.10 |
| Return on Assets (ROA) | 0.06 |
| Return on Equity (ROE) | 0.14 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.99 |
| Current Ratio | 1.76 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 38.81 |
| Assets | 61.46 |
| Liabilities | 33.76 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 200.16 |
| Operating Income | 4.33 |
| Net Income | 2.94 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 12.20 |
| Cash from Investing | -2.25 |
| Cash from Financing | -14.42 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Radoff Bradley Louis | 4.99 | -26.39 | |
| 13D/A | Sudbury Capital Management, LLC | 5.90 | 0.00 | |
| 13G/A | Renaissance Technologies Llc | 6.51 | -2.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 5,625 | 30,671 | 18.34 | |
| 13,480 | 78,157 | 17.25 | |
| 24,603 | 93,285 | 26.37 | |
| 5,919 | 56,801 | 10.42 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KTTA – Pasithea Therapeutics Corp. | KZR – Kezar Life Sciences, Inc. |
| LEXX – Lexaria Bioscience Corp. | LGVN – Longeveron Inc. |
| LIPO – Lipella Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io